KAPA
Kairos Pharma, Ltd.
NYSE MKT: KAPA · HEALTHCARE · BIOTECHNOLOGY
$0.55
-6.44% today
Updated 2026-04-29
Market cap
$12.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
0.6M
Kairos Pharma, Ltd. (KAPA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-98.00%
ROA
-56.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-1.05M | — | — | — |
| 2021 | $0.00 | $-2.15M | — | — | — |
| 2022 | $0.00 | $-1.05M | — | — | — |
| 2023 | $0.00 | $-1.81M | — | — | — |
| 2024 | $0.00 | $-2.60M | — | — | — |
| 2025 | $0.00 | $-5.45M | — | — | — |